Artificial Intelligence-Integrated BOPPPS Case-Based Learning for Nephrology Clerkship Education

September 11, 2026 updated by: The Second Hospital of Shandong University

Artificial Intelligence-Integrated BOPPPS Case-Based Learning for Nephrology Clerkship Education: A Three-Arm Cluster Randomized Controlled Educational Trial

This prospective, three-arm, parallel-group, cluster randomized controlled educational trial was conducted among third-year undergraduate medical students undertaking nephrology clerkship at The Second Hospital of Shandong University. The study aimed to compare the effects of lecture-based learning, BOPPPS combined with case-based learning, and artificial intelligence-integrated BOPPPS combined with case-based learning on students' theoretical knowledge, clinical reasoning, clinical case analysis, and critical appraisal of AI-generated clinical recommendations.

Existing clinical clerkship teaching groups, rather than individual students, were randomized to one of three educational interventions: lecture-based learning (LBL), BOPPPS combined with case-based learning (BOPPPS-CBL), or artificial intelligence-integrated BOPPPS combined with case-based learning (AI-BOPPPS-CBL). Twelve teaching groups were randomized in a 1:1:1 ratio, with four teaching groups assigned to each arm.

All groups received standardized instruction on acute kidney injury and chronic renal failure delivered by the same teaching team.

The BOPPPS-CBL intervention incorporated structured learning activities including case discussion, progressive case disclosure, clinical reasoning exercises, and feedback.

The AI-integrated group additionally used AI-generated clinical scenarios and diagnostic and treatment recommendations as materials for critical appraisal. Students identified potential errors or limitations in AI-generated content and proposed revisions based on textbooks, clinical guidelines, and evidence-based resources.

The primary outcome was the clinical case analysis score. Secondary outcomes included theoretical test scores, knowledge gain, clinical reasoning score, AI critical appraisal score, and course feedback.

Study Overview

Detailed Description

This prospective, three-arm, parallel-group, cluster randomized controlled educational trial was conducted among third-year undergraduate medical students undertaking nephrology clerkship at The Second Hospital of Shandong University.

Existing clinical clerkship teaching groups served as the units of randomization. Twelve teaching groups were randomized in a 1:1:1 ratio to lecture-based learning (LBL), BOPPPS combined with case-based learning (BOPPPS-CBL), or artificial intelligence-integrated BOPPPS combined with case-based learning (AI-BOPPPS-CBL), with four teaching groups assigned to each arm.

All groups received standardized instruction on acute kidney injury and chronic renal failure delivered by the same teaching team. The BOPPPS-CBL intervention incorporated structured learning activities including case discussion, progressive case disclosure, clinical reasoning exercises, and feedback. The AI-integrated group additionally used AI-generated clinical scenarios and diagnostic and treatment recommendations as materials for critical appraisal. Students identified potential errors or limitations in AI-generated content and proposed revisions based on textbooks, clinical guidelines, and evidence-based resources.

The primary outcome was the clinical case analysis score. Secondary outcomes included theoretical test scores, knowledge gain, clinical reasoning score, AI critical appraisal score, and course feedback.

Study Type

Interventional

Enrollment (Actual)

192

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shandong
      • Jinan, Shandong, China, 250000
        • The Second Hospital of Shandong University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Third-year undergraduate medical students in the clinical medicine program of Shandong University undertaking the nephrology clerkship at The Second Hospital of Shandong University.
  • Completion of the required theoretical courses in pathophysiology and internal medicine before study participation.
  • Provision of written informed consent.

Exclusion Criteria:

- Previous nephrology clinical clerkship or internship experience, or previous participation in additional nephrology-focused training beyond the standard pre-clerkship curriculum.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Lecture-Based Learning
Students received traditional lecture-based learning during nephrology clerkship education. Standardized instruction on acute kidney injury and chronic renal failure was provided by the teaching team.
Students received traditional lecture-based learning during nephrology clerkship education. Standardized teaching on acute kidney injury and chronic renal failure was delivered by the teaching team using conventional instructional methods.
Experimental: BOPPPS Combined With Case-Based Learning
Students received a BOPPPS structured teaching model combined with case-based learning activities. The intervention included progressive clinical case discussion, clinical reasoning exercises, and feedback during nephrology clerkship education.
Students received a structured BOPPPS teaching model combined with case-based learning activities during nephrology clerkship education. The intervention included case discussion, progressive case disclosure, clinical reasoning exercises, and feedback from instructors.
Experimental: AI-Integrated BOPPPS Combined With Case-Based Learning
Students received an artificial intelligence-integrated BOPPPS case-based learning model. AI-generated clinical scenarios and diagnostic and treatment recommendations were used as learning materials for critical appraisal. Students evaluated AI-generated content and revised potential errors based on clinical guidelines and evidence-based resources.
Students received an artificial intelligence-integrated BOPPPS case-based learning model. AI-generated clinical scenarios and diagnostic and treatment recommendations were used as learning materials for critical appraisal. Students evaluated AI-generated content and identified potential errors or limitations based on clinical guidelines and evidence-based resources.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study-Specific Clinical Case Analysis Assessment Total Score
Time Frame: Immediately after completion of the educational intervention
Clinical case analysis performance was assessed using a study-specific three-case written assessment developed by the nephrology teaching team. The assessment evaluated students' ability to apply nephrology knowledge to clinical case analysis, diagnostic reasoning, treatment planning, and critical appraisal of AI-generated clinical recommendations. Total scores ranged from 0 to 70 points, with higher scores indicating better overall clinical case analysis performance.
Immediately after completion of the educational intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study-Specific Post-Class Theoretical Knowledge Test Score
Time Frame: Immediately after completion of the educational intervention
Theoretical knowledge was assessed using a study-specific post-class test covering acute kidney injury and chronic kidney disease. The test consisted of 15 single-choice questions, with each correct answer worth 2 points. Total scores ranged from 0 to 30 points, with higher scores indicating better theoretical knowledge performance.
Immediately after completion of the educational intervention
Study-Specific Clinical Case Analysis Assessment: Clinical Reasoning Component Score
Time Frame: Immediately after completion of the educational intervention
Clinical reasoning was assessed using Cases 1 and 2 of the study-specific Clinical Case Analysis Assessment. The cases addressed acute kidney injury and chronic kidney disease and evaluated students' ability to identify clinical problems, interpret clinical and laboratory information, formulate diagnoses, assess complications, and develop appropriate management plans. Scores ranged from 0 to 48 points, with higher scores indicating better clinical reasoning performance.
Immediately after completion of the educational intervention
Study-Specific Clinical Case Analysis Assessment: AI Critical Appraisal Component Score
Time Frame: Immediately after completion of the educational intervention
AI critical appraisal ability was assessed using Case 3 of the study-specific Clinical Case Analysis Assessment. Students evaluated an AI-generated treatment plan for a patient with acute kidney injury and severe hyperkalemia, identified clinically inappropriate or unsafe recommendations, explained the reasons, prioritized immediate management, and proposed an appropriate treatment plan. Scores ranged from 0 to 22 points, with higher scores indicating better ability to critically appraise AI-generated clinical recommendations.
Immediately after completion of the educational intervention
Knowledge Gain in Theoretical Knowledge Test Score
Time Frame: Change from immediately before the educational intervention to immediately after completion of the educational intervention
Knowledge gain was calculated as the post-class theoretical knowledge test score minus the pre-class theoretical knowledge test score. Both tests consisted of 15 single-choice questions and had possible total scores ranging from 0 to 30 points. Therefore, knowledge gain scores could range from -30 to +30 points. Higher values indicate greater improvement in theoretical knowledge, a score of 0 indicates no change, and negative values indicate a lower post-class than pre-class score.
Change from immediately before the educational intervention to immediately after completion of the educational intervention
Study-Specific Course Feedback Questionnaire Total Score
Time Frame: Immediately after completion of the educational intervention
Course feedback was assessed using a study-specific 8-item questionnaire developed by the research team. Items assessed perceived learning gains and teaching satisfaction. Each item was rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores ranged from 8 to 40 points, with higher scores indicating more favorable perceptions of the educational experience.
Immediately after completion of the educational intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fulin Dou, The Second Hospital of Shandong University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 17, 2025

Primary Completion (Actual)

December 1, 2025

Study Completion (Actual)

December 1, 2025

Study Registration Dates

First Submitted

August 24, 2026

First Submitted That Met QC Criteria

September 11, 2026

First Posted (Actual)

September 15, 2026

Study Record Updates

Last Update Posted (Actual)

September 15, 2026

Last Update Submitted That Met QC Criteria

September 11, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • AI-BOPPPS-Nephro-2025
  • MR-37-26-055587 (Registry Identifier: National Medical Research Registration and Filing System)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be made available because the dataset contains individual-level educational performance and assessment information from medical students, and sharing such data may pose privacy and confidentiality concerns. Aggregated study results will be reported in scientific publications.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe